Balance Sheet
Accumulated ExpensesAssetsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HUTCHMED (China) (HCM) Current Assets: 2015-2025

Historic Current Assets for HUTCHMED (China) (HCM) over the last 2 years, with Jun 2025 value amounting to $1.6 billion.

  • HUTCHMED (China)'s Current Assets rose 51.90% to $1.6 billion in Q2 2025 from the same period last year, while for Jun 2025 it was $1.6 billion, marking a year-over-year increase of 51.90%. This contributed to the annual value of -$67.6 million for FY2024, which is 8.63% up from last year.
  • Latest data reveals that HUTCHMED (China) reported Current Assets of $1.6 billion as of Q2 2025, which was up 2,456.87% from -$67.6 million recorded in Q4 2024.
  • HUTCHMED (China)'s 5-year Current Assets high stood at $1.6 billion for Q2 2025, and its period low was -$73.9 million during Q4 2023.
  • Over the past 3 years, HUTCHMED (China)'s median Current Assets value was $1.0 billion (recorded in 2024), while the average stood at $717.9 million.
  • Per our database at Business Quant, HUTCHMED (China)'s Current Assets surged by 191.19% in 2021 and then plummeted by 108.80% in 2023.
  • HUTCHMED (China)'s Current Assets (Quarterly) stood at $1.2 billion in 2021, then slumped by 30.71% to $839.9 million in 2022, then slumped by 108.80% to -$73.9 million in 2023, then rose by 8.63% to -$67.6 million in 2024, then spiked by 51.90% to $1.6 billion in 2025.
  • Its last three reported values are $1.6 billion in Q2 2025, -$67.6 million for Q4 2024, and $1.0 billion during Q2 2024.